Browse > Article
http://dx.doi.org/10.5483/BMBRep.2020.53.9.050

Protocadherin-7 contributes to maintenance of bone homeostasis through regulation of osteoclast multinucleation  

Kim, Hyunsoo (Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine)
Takegahara, Noriko (Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine)
Walsh, Matthew C. (Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine)
Ueda, Jun (Research Institute for Microbial Diseases, Osaka University)
Fujihara, Yoshitaka (Research Institute for Microbial Diseases, Osaka University)
Ikawa, Masahito (Research Institute for Microbial Diseases, Osaka University)
Choi, Yongwon (Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine)
Publication Information
BMB Reports / v.53, no.9, 2020 , pp. 472-477 More about this Journal
Abstract
Osteoclasts are hematopoietic-derived cells that resorb bone. They are required to maintain proper bone homeostasis and skeletal strength. Although osteoclast differentiation depends on receptor activator of NF-κB ligand (RANKL) stimulation, additional molecules further contribute to osteoclast maturation. Here, we demonstrate that protocadherin-7 (Pcdh7) regulates formation of multinucleated osteoclasts and contributes to maintenance of bone homeostasis. We found that Pcdh7 expression is induced by RANKL stimulation, and that RNAi-mediated knockdown of Pcdh7 resulted in impaired formation of osteoclasts. We generated Pcdh7-deficient mice and found increased bone mass due to decreased bone resorption but without any defect in bone formation. Using an in vitro culture system, it was revealed that formation of multinucleated osteoclasts is impaired in Pcdh7-deficient cultures, while no apparent defects were observed in differentiation and function of Pcdh7-deficient osteoblasts. Taken together, these results reveal an osteoclast cell-intrinsic role for Pcdh7 in maintaining bone homeostasis.
Keywords
Bone homeostasis; Maturation; Multinucleation; Osteoclast; Pcdh7;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Peek SL, Mah KM and Weiner JA (2017) Regulation of neural circuit formation by protocadherins. Cell Mol Life Sci 74, 4133-4157   DOI
2 Nakamura H, Nakashima T, Hayashi M et al (2014) Global epigenomic analysis indicates protocadherin-7 activates osteoclastogenesis by promoting cell-cell fusion. Biochem Biophys Res Commun 455, 305-311   DOI
3 Helming L and Gordon S (2009) Molecular mediators of macrophage fusion. Trends Cell Biol 19, 514-522   DOI
4 Oren-Suissa M and Podbilewicz B (2007) Cell fusion during development. Trends Cell Biol 17, 537-546   DOI
5 Kim H, Takegahara N, Walsh MC et al (2020) IgSF11 regulates osteoclast differentiation through association with the scaffold protein PSD-95. Bone Res 8, 5   DOI
6 Kahr I, Vandepoele K and van Roy F (2013) Delta-protocadherins in health and disease. Prog Mol Biol Transl Sci 116, 169-192   DOI
7 Heggem M and Bradley R (2003) The cytoplasmic domain of Xenopus NF-protocadherin interacts with TAF1/set. Dev Cell 4, 419-429   DOI
8 Bradley R, Espeseth A and Kintner C (1998) NF-protocadherin, a novel member of the cadherin superfamily, is required for Xenopus ectodermal differentiation. Curr Biol 8, 325-334   DOI
9 Zhou X, Updegraff BL, Guo Y et al (2017) PROTOCA DHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis. Cancer Res 77, 187-197   DOI
10 Wang L, Guo X, Zhou W et al (2018) Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption. Acta Biomater 73, 488-499   DOI
11 Vanhalst K, Kools P, Staes K, van Roy F and Redies C (2005) delta-Protocadherins: a gene family expressed differentially in the mouse brain. Cell Mol Life Sci 62, 1247-1259   DOI
12 Walsh MC, Kim N, Kadono Y et al (2006) Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 24, 33-63   DOI
13 Matsuo K and Irie N (2008) Osteoclast-osteoblast communication. Arch Biochem Biophys 473, 201-209   DOI
14 Miyazaki T, Tokimura F and Tanaka S (2014) A review of denosumab for the treatment of osteoporosis. Patient Prefer Adherence 8, 463-471   DOI
15 Baron R, Ferrari S and Russell RG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48, 677-692   DOI
16 Zaidi M (2007) Skeletal remodeling in health and disease. Nat Med 13, 791-801   DOI
17 Moutsopoulos NM, Konkel J, Sarmadi M et al (2014) Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss. Sci Transl Med 6, 229ra40   DOI
18 Souza PP and Lerner UH (2013) The role of cytokines in inflammatory bone loss. Immunol Invest 42, 555-622   DOI
19 Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7, 292-304   DOI
20 Boyle JW, Simonet SW and Lacey LD (2003) Osteoclast differentiation and activation. Nature 423, 337-342   DOI
21 Aguilar PS, Baylies MK, Fleissner A et al (2013) Genetic basis of cell-cell fusion mechanisms. Trends Genet 29, 427-437   DOI
22 Kim H, Walsh MC, Takegahara N et al (2017) The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts. Sci Rep 7, 196   DOI
23 Hayashi S and Takeichi M (2015) Emerging roles of protocadherins: from self-avoidance to enhancement of motility. J Cell Sci 128, 1455-1464   DOI
24 Takeichi M (2014) Dynamic contacts: rearranging adherens junctions to drive epithelial remodelling. Nat Rev Mol Cell Biol 15, 397-410   DOI
25 Leckband DE and de Rooij J (2014) Cadherin adhesion and mechanotransduction. Annu Rev Cell Dev Biol 30, 291-315   DOI
26 Teitelbaum SL and Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4, 638-649   DOI
27 Kim SY, Yasuda S, Tanaka H, Yamagata K and Kim H (2011) Non-clustered protocadherin. Cell Adh Migr 5, 97-105   DOI